VX1 vs Reveal LINQ Insertable Cardiac Monitor

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

VX1

by Volta Medical

Reveal LINQ Insertable Cardiac Monitor

by Medtronic

AI Verdict

Volta Medical's VX1 is an AI software designed to assist cardiac electrophysiologists in real-time during atrial fibrillation and atrial tachycardia ablation procedures, focusing on identifying specific electrograms. In contrast, Medtronic's Reveal LINQ Insertable Cardiac Monitor is an implantable device that provides long-term, continuous heart monitoring with AI to reduce false alerts and enhance diagnostic yield for conditions like atrial fibrillation. While both utilize AI in cardiology, VX1 is an intra-procedural guidance tool, whereas the Reveal LINQ ICM is a long-term diagnostic monitoring solution.

Choose VX1 if…

Choose VX1 if your primary need is real-time, AI-guided assistance *during* complex atrial fibrillation or atrial tachycardia ablation procedures. This tool is ideal for electrophysiologists seeking to enhance precision and standardize outcomes by leveraging AI to identify dispersed electrograms in the electrophysiology lab. It integrates with existing EP systems to provide immediate insights for surgical intervention.

View VX1 →

Choose Reveal LINQ Insertable Cardiac Monitor if…

Choose the Reveal LINQ Insertable Cardiac Monitor if you require long-term, continuous, and discreet monitoring for the diagnosis of infrequent or asymptomatic cardiac arrhythmias such as atrial fibrillation or syncope. This implantable device offers extended battery life and utilizes AI algorithms to significantly reduce false alerts, providing accurate diagnostic data remotely over several years. It is best suited for patients needing prolonged monitoring without active intervention.

View Reveal LINQ Insertable Cardiac Monitor →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	VX1	Reveal LINQ Insertable Cardiac Monitor
Pricing	Contact for pricing	Contact vendor
Deployment	Software integrated with existing electrophysiology (EP) lab mapping and recording systems.	Implantable device with data transmitted to a cloud-based platform (CareLink™ network) via patient smartphone app or home communicator.
BAA Available	Unknown	Yes AI-estimated
FDA Status	Cleared AI-estimated	Yes AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

VX1

Tool A integrates directly into existing EP lab systems, assisting electrophysiologists in real-time during procedures, which streamlines their current workflow. Tool B, while beneficial for long-term monitoring, involves a surgical implant and relies on patient interaction with a mobile app or home communicator for data transmission, potentially introducing patient-side usability challenges.

Clinical Value

Tie

Both tools offer significant clinical value in different aspects of cardiac care. Tool A aims to improve the efficacy and standardization of AFib ablation procedures in real-time. Tool B focuses on enhancing diagnostic yield and reducing false alerts in long-term cardiac monitoring, which can lead to more efficient patient management.

Pricing & Value

Tie

Neither tool provides publicly available pricing information, requiring direct contact with the respective vendors. Without transparent pricing details, it is impossible to conduct a meaningful head-to-head comparison of their value propositions.

Enterprise Readiness

Reveal LINQ Insertable Cardiac Monitor

Tool B explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA), which are crucial for healthcare enterprise adoption. Medtronic, as a large and established medical device company, also brings a robust infrastructure for deployment, security, and ongoing management, which are key indicators of enterprise readiness.

Innovation

VX1

Tool A's real-time AI-guided identification of dispersed electrograms during live ablation procedures represents a highly innovative application of AI for immediate procedural enhancement. While Tool B's deep learning for false alert reduction in long-term monitoring is also innovative, the real-time, intra-procedural guidance of Tool A addresses a more complex and immediate clinical challenge.

Support & Docs

Reveal LINQ Insertable Cardiac Monitor

While both companies offer documentation, Medtronic (Tool B) demonstrates a more extensive and established support infrastructure, including dedicated technical and patient service phone lines, online self-help resources, and comprehensive patient education materials. Volta Medical (Tool A) provides access to user manuals and brochures, but its support ecosystem appears less comprehensive in comparison.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	VX1	Reveal LINQ Insertable Cardiac Monitor
Name	VX1	Reveal LINQ Insertable Cardiac Monitor
Company	Volta Medical	Medtronic
Description	Volta Medical's VX1 is an FDA-cleared AI software that assists cardiac electrophysiologists in real-time identification of dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures.	The Medtronic LINQ IIu2122 Insertable Cardiac Monitor (ICM) with AccuRhythmu2122 AI algorithms provides long-term, accurate heart monitoring by using deep learning AI to reduce false alerts and enhance diagnostic yield for conditions like atrial fibrillation and syncope.
Categories	Cardiology AI, Surgical AI	Cardiology AI, Wearables & Remote Monitoring (RPM)
Specialties	Cardiology	Cardiology, Pediatrics

Videos

Demos, reviews, and walkthroughs featuring VX1 and Reveal LINQ Insertable Cardiac Monitor.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How does each tool specifically enhance clinical decision-making during different phases of patient care?

VX1 assists cardiac electrophysiologists in real-time identification of dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures. The Reveal LINQ ICM provides long-term, continuous ECG monitoring with AI algorithms to reduce false alerts and enhance diagnostic yield for conditions like atrial fibrillation and syncope.

What is the depth of integration with existing clinical systems for each tool, particularly regarding workflow fit in the EP lab versus remote monitoring?

VX1 is software integrated with existing electrophysiology lab mapping and recording systems to provide real-time AI guidance during procedures. The Reveal LINQ ICM is an implantable device with data transmitted remotely to a cloud-based platform (CareLinku2122 network) via patient smartphone app or home communicator.

Can you elaborate on the specific accuracy and sensitivity improvements offered by the AI algorithms in each device?

VX1 features AI-guided real-time identification of dispersed electrograms and a Booster mode for increased sensitivity during atrial tachycardia or slow atrial fibrillation. The Reveal LINQ ICM utilizes AccuRhythmu2122 AI algorithms specifically designed to reduce false alerts for atrial fibrillation and pauses, thereby enhancing diagnostic yield.

For which specific cardiac conditions or procedural contexts is each tool primarily designed?

VX1 is primarily designed for cardiac electrophysiologists assisting in atrial fibrillation and atrial tachycardia ablation procedures. The Reveal LINQ ICM is intended for long-term, continuous subcutaneous ECG monitoring to diagnose conditions such as atrial fibrillation and syncope, applicable in cardiology and pediatrics.

What features support clinical adjudication or review of AI-generated insights or monitored events?

VX1 provides real-time AI-guided identification of electrograms during procedures, designed to reduce inter-operator variability and standardize outcomes. The Reveal LINQ ICM offers an enhanced ECG experience for clinical adjudication, leveraging its AccuRhythmu2122 AI algorithms to improve the clarity and relevance of monitored data.

How do these tools address the potential for variability in clinical outcomes or diagnostic accuracy?

VX1 is designed to reduce inter-operator variability and standardize outcomes during AFib and atrial tachycardia ablation procedures through AI-guided real-time identification. The Reveal LINQ ICM employs AccuRhythmu2122 AI algorithms to reduce false alerts for AF and Pause, thereby enhancing diagnostic yield and improving the accuracy of long-term monitoring.